
Enable Biosciences: A San Francisco-based firm developing ultrasensitive diagnostics for early disease detection.
Founded in South San Francisco, Enable Biosciences is a diagnostics company focused on developing ultrasensitive immunoassays for the early detection and treatment of autoimmune and infectious diseases. Spun out of UC Berkeley and Stanford, the company aims to create precision medicine tools that can predict and diagnose diseases at their earliest stages. Their products are designed for use in healthcare settings to improve patient outcomes through timely intervention.
Enable Biosciences has notable affiliations with prestigious institutions such as Stanford Healthcare, Harvard Medical School, and the California Department of Public Health. They have also collaborated with organizations like JDRF. The company has performed over a significant number of tests, demonstrating their impact in the field of predictive medicine. Their innovative approach has positioned them as a key player in the diagnostics industry, contributing to advancements in early disease detection and patient care.

Amplified Sciences

Enable Medicine
enablemedicine.com

Pediatric Bioscience

E25Bio
e25bio.com

Genendeavor
genendeavor.com

Accelevir Diagnostics

Predictive Health Diagnostics Company

Enable Therapeutics

Spear Bio
spear.bio

BioAnalytics

Modular Bioscience

Santa Ana Bio
santaanabio.com

EDP Biotech
edpbiotech.com

Scribe Biosciences

Predictive Biosciences
Companies similar to Enable Biosciences include Amplified Sciences, Enable Medicine, Pediatric Bioscience and E25Bio.
Enable Biosciences was founded in 2015.
Enable Biosciences' headquarters is located in South San Francisco, CA, US.
Enable Biosciences' most recent funding round was for $1.5M (USD) in November 2019.
As of Nov 19, 2019, Enable Biosciences has raised a total of $4.2M (USD).
Enable Biosciences has 11 employees as of Feb 4, 2024.